QQQ 416.36 (-1.67%)

AAPL 165.13 (-1.14%)

MSFT 401.05 (-0.80%)

META 485.91 (-3.17%)

GOOGL 154.54 (-0.94%)

AMZN 175.54 (-2.05%)

TSLA 148.64 (-0.86%)

NVDA 796.73 (-5.90%)

AMD 149.37 (-3.68%)

NIO 3.83 (-4.25%)

BABA 68.96 (+0.12%)

T 16.41 (+0.49%)

F 12.13 (+0.58%)

MU 107.36 (-4.08%)

GE 149.59 (-2.19%)

CGC 8.12 (+3.70%)

DIS 112.30 (-0.12%)

AMC 3.23 (+10.62%)

PFE 25.83 (+1.73%)

PYPL 62.18 (+0.13%)

XOM 119.99 (+1.24%)

QQQ 416.36 (-1.67%)

AAPL 165.13 (-1.14%)

MSFT 401.05 (-0.80%)

META 485.91 (-3.17%)

GOOGL 154.54 (-0.94%)

AMZN 175.54 (-2.05%)

TSLA 148.64 (-0.86%)

NVDA 796.73 (-5.90%)

AMD 149.37 (-3.68%)

NIO 3.83 (-4.25%)

BABA 68.96 (+0.12%)

T 16.41 (+0.49%)

F 12.13 (+0.58%)

MU 107.36 (-4.08%)

GE 149.59 (-2.19%)

CGC 8.12 (+3.70%)

DIS 112.30 (-0.12%)

AMC 3.23 (+10.62%)

PFE 25.83 (+1.73%)

PYPL 62.18 (+0.13%)

XOM 119.99 (+1.24%)

QQQ 416.36 (-1.67%)

AAPL 165.13 (-1.14%)

MSFT 401.05 (-0.80%)

META 485.91 (-3.17%)

GOOGL 154.54 (-0.94%)

AMZN 175.54 (-2.05%)

TSLA 148.64 (-0.86%)

NVDA 796.73 (-5.90%)

AMD 149.37 (-3.68%)

NIO 3.83 (-4.25%)

BABA 68.96 (+0.12%)

T 16.41 (+0.49%)

F 12.13 (+0.58%)

MU 107.36 (-4.08%)

GE 149.59 (-2.19%)

CGC 8.12 (+3.70%)

DIS 112.30 (-0.12%)

AMC 3.23 (+10.62%)

PFE 25.83 (+1.73%)

PYPL 62.18 (+0.13%)

XOM 119.99 (+1.24%)

QQQ 416.36 (-1.67%)

AAPL 165.13 (-1.14%)

MSFT 401.05 (-0.80%)

META 485.91 (-3.17%)

GOOGL 154.54 (-0.94%)

AMZN 175.54 (-2.05%)

TSLA 148.64 (-0.86%)

NVDA 796.73 (-5.90%)

AMD 149.37 (-3.68%)

NIO 3.83 (-4.25%)

BABA 68.96 (+0.12%)

T 16.41 (+0.49%)

F 12.13 (+0.58%)

MU 107.36 (-4.08%)

GE 149.59 (-2.19%)

CGC 8.12 (+3.70%)

DIS 112.30 (-0.12%)

AMC 3.23 (+10.62%)

PFE 25.83 (+1.73%)

PYPL 62.18 (+0.13%)

XOM 119.99 (+1.24%)

Emergent BioSolutions (EBS) Social Media Sentiment and Mentions

→ Biden replacement revealed? (From Paradigm Press) (Ad)

Free EBS Stock Alerts

$2.00

+0.14 (+7.53%)

(As of 02:02 PM ET)

WallStreetBets Posts Over Time

View Trending WallStreetBets Stocks

Media Mentions Over Time

1
Last Week

3
Current Week

+200.0%

View Trending Media Stocks

MarketBeat New Follows Over Time

1
Last Week

1
Current Week

View Trending Stocks on MarketBeat

MarketBeat Searches Over Time

1
Last Week

3
Current Week

+200.0%

Recieve Emergent BioSolutions News and Ratings via Email

Sign-up to receive the latest news and ratings for EBS and its competitors with MarketBeat's FREE daily newsletter.

EBS Social Media Mentions

Your Next Portfolio Star: Revealing 2024's Top Stock Pick

We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

Click here to download your report

Related Companies and Tools

Related Companies:

Social Media Tools:

This page (NYSE:EBS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Web Analytics

Get 30 Days of MarketBeat All Access Free

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial